Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma

Pharmaceutics(2025)10.3390/pharmaceutics17101334Source: DataRank Database

Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma is a research paper published in Pharmaceutics (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: goldTopics (17)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Hari Krishnareddy Rachamala,Shamit K. Dutta,Enfeng Wang ORCID,Krishnendu Pal ORCID,Debabrata Mukhopadhyay ORCID

Live enrichment

PubMed:41155969 PMC:PMC12567285 OpenAlex:https://openalex.org/W4415209035

National Institute of Health

Grant: R01CA150190

National Institute of Health

Grant: R01NS129671

National Institute of Health

Grant: P30CA015083

State of Florida Casey DeSantis Cancer Research Program

Grant: MOG22-82

DoD

Grant: W81XWH-21-1-0678

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4923/17/10/1334/pdf?version=1760516326

publisherhttps://www.mdpi.com/1999-4923/17/10/1334/pdf?version=1760516326

publisherhttps://www.mdpi.com/1999-4923/17/10/1334/pdf

journalhttps://doi.org/10.3390/pharmaceutics17101334

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41155969

Fields of Study

RNA modifications and cancerCancer, Lipids, and MetabolismPancreatic and Hepatic Oncology Research

Keywords

Pancreatic cancerGemcitabineIn vivoGene silencingCancerSystemic administrationStromal cellPancreatic ductal adenocarcinomaTumor progressionRNA interference (RNAi)Sirna DeliveryGipc1Pancreatic Ductal Adenocarcinoma (Pdac)Lipid Nanoparticles (Lnps)